As an expert in the field of oncology, I can provide you with an informed perspective on living with bone cancer. Bone cancer is a complex disease, and the ability to live with it depends on several factors, including the type of cancer, its stage at diagnosis, and the treatment options available. Cancer types such as osteosarcoma and Ewing sarcoma are two of the most common bone cancers. When these cancers are localized, meaning they have not spread to other parts of the body, the 5-year survival rate is relatively high, ranging from about 60 to 80 percent. This indicates that a significant number of patients can expect to live for at least five years after their diagnosis. However, if the cancer has metastasized, or spread to distant parts of the body, the prognosis is less favorable. In such cases, the 5-year survival rate drops to about 15 to 30 percent. Despite these statistics, advances in medical treatments, including surgery, chemotherapy, and radiation therapy, have improved the quality of life and survival rates for many patients with bone cancer. It's important to note that survival rates are based on large groups of people and may not predict what will happen for any individual patient. Each person's response to treatment and the progression of their disease is unique. Additionally, the psychological and social aspects of living with bone cancer are also significant and require a multidisciplinary approach to care, involving not only medical professionals but also social workers, psychologists, and support groups. In conclusion, while living with bone cancer can be challenging, it is possible for many patients, especially when the cancer is diagnosed and treated early. The key is to work closely with a team of healthcare professionals to receive the best possible care and support. read more >>

However, this varies by cancer type and stage. For osteosarcomas and Ewing sarcomas that are still in the area where they started (localized), the 5-year survival rate is about 60 to 80 percent. If the cancer has spread to distant parts of the body, the 5-year survival rate is about 15 to 30 percent.read more >>